Galectin-1 靶点蛋白|抗体药物|临床药物信息 - ACROBiosystems中国

> 【Galectin-1】

Galectin-1信息

英文名称：Galectin-1
中文名称：半乳糖凝集素1
靶点别称：Epididymis Secretory Sperm Binding Protein，Lectin， Galactoside-Binding， Soluble， 1，Beta-Galactoside-Binding Lectin L-14-I，14 KDa Laminin-Binding Protein，S-Lac Lectin 1，14 KDa Lectin，Galaptin，HLBP14，Gal-1，HPL，Beta-Galactoside-Binding Protein 14kDa，Lectin Galactoside-Binding Soluble 1，GAL1，GBP，Galectin 1，Putative MAPK-activating protein PM12，Galectin-1，HBL，LGALS1，Lactose-binding lectin 1

上市药物数量：1
临床药物数量：1
最高研发阶段：批准上市

Galectin-1产品列表

筛选结果

产品库

在线 (1)

物种

Human (1)

标签

Tag Free (1)

属性

Protein (1)

标记

Unconjugated (1)

货号	物种	产品描述	蛋白结构	纯度	活性
GA1-H4113	Human	Human Galectin-1 / LGALS1 Protein, Tag Free (MALS verified)

ACRO质量管理体系

评论(1)

GA1-H4113|Human Galectin-1 / LGALS1 Protein, Tag Free (MALS verified)

+49XXXXXXX4732

1人赞

Dear Sir or Madam, I had an overall good service from Acro Biosystems. Shipment was fast and product quality was good. Got the protocol for QC after asking the customer service. Protocol for QC was easy to understand and repeat. Easy way to download the Certificate of Analysis via the printed QR code on product vials. Customer service answered very fast and was very friendly. QC of Human Galectin-1 protein vs. biotinylated human CD45 protein (CD5-H82E7) was fine.
>
2022-01-01

Galectin-1分子别名

LGALS1,GAL1,GBP,Galectin-1,DKFZp686E23103

Galectin-1分子背景

Galectin-1 (Gal-1), a member of the β-galactoside-binding animal lectin family, has a wide range of biological activities, which makes it an attractive target for medical applications. Gal-1 is ubiquitously but differentially expressed in normal and pathological animal tissues, and a variety of biological activities, including modulation of innate and adaptive immune responses, malignant progression of tumor cells, etc.

Galectin-1上市药物信息

英文名称	中文名称	研发代码	研发阶段	公司	最早商品名	最早批准国家	最早适应症	最早批准公司	最早批准日期	适应症	临床试验
Ocriplasmin		A-01016; THR-409	批准上市	Thrombogenics	Jetrea, Jejetrea	United States	玻璃体黄斑粘连	Thrombogenics Inc	2012-10-17	玻璃体脱离, 动脉闭塞性疾病, 疾病进展, 中风, 视网膜病变, 糖尿病黄斑水肿, 葡萄膜炎, 玻璃体黄斑粘连, 眼部疾病, 静脉血栓形成, 年龄相关性黄斑变性, 糖尿病视网膜病变, 视网膜静脉阻塞	详情

Galectin-1临床药物信息

英文名称	研发代码	研发阶段	公司	适应症	临床试验
Olitigaltin	GB-0139; TD-139	临床二期	The University Of Edinburgh, Lund University Foundation	特发性肺纤维化, 新型冠状病毒感染	详情

扫一扫关注微信公众号获取ACRO最新资讯

ACROBiosystems百普赛斯生物科技股份有限公司

全国：+86 400-682-2521

北京：010-53681107

上海：021-50850665

海外：+1 800-810-0816

邮箱：（产品订购）order.cn@acrobiosystems.com

邮箱：（技术支持）tech.cn@acrobiosystems.com

邮箱：（廉洁合规）lianjie@acrobiosystems.com

地址：北京经济技术开发区宏达北路8号5号楼4层

在线留言

发送

消息提示

请输入您的联系方式,再点击提交！